BioCorp, An Innovative Medical Device Company, Announces The Formation Of Its Scientific Advisory Board
Three leading diabetologists join the company
Issoire, May 7, 2015 - BIOCORP, a French company specializing in the development and manufacturing of highly innovative medical devices and drug delivery systems, announced today the formation of its Scientific Advisory Board with the appointment of Lutz Heinemann, Ph.D.; Jean-Pierre Riveline, M.D.; and Pauline Schaepelynck-Belicar, M.D.
A Process Engineer (1976, University of Düsseldorf, Germany) and Doctor of Biology (1993, University of Düsseldorf, Germany), Lutz Heinemann began dedicating himself to internal medicine in 1985, when he worked alongside Professor M. Berger at the Clinic for Nutrition and Metabolism, a division of the Centre for Internal Medicine and Neurology at the University of Düsseldorf. In 1999, he founded the Profil Institute for Metabolic Research (Neuss, Germany), a sister institute dedicated to clinical diabetes studies, which, under his leadership, became one of most prominent research centers in the field. Since stepping down as the Head of the institute in 2009, he has maintained some involvement in the center's activities as a scientific advisor. Professor Lutz Heinemann is a member of several scientific societies, including the German Diabetes Association (DDG), European Association for the Study of Diabetes (EASD) and American Diabetes Association (ADA), and he sits on the scientific advisory boards of various pharmaceutical and diagnostic companies. He was a recipient of the "Leadership in Diabetes Technology" award in 2007 and the "Artificial Pancreas Research Award" in 2012 from the Diabetes Technology Society. A coordinator for the European project AP@home from 2010 to 2015, Lutz Heinemann has also served since 2011 as managing editor for the Journal of Diabetes Science and Technology.
A Doctor of Medicine (1998, University of Paris VI, France) and a Doctor of Science (2013, University of Paris VI, France), acting as a lead researcher since 2014, Jean-Pierre Riveline specializes in endocrinology and diabetology at the Cochin and Lariboisière hospitals in Paris, France. His research and teaching focus mainly on the physiological and technological aspects surrounding diabetes. A Member of the EASD and the Société Francophone du Diabète (SFD, French Society of Diabetes), he also serves as general secretary for several nonprofit French organizations dedicated to diabetes, including the French multicenter study group EVADIAC (Evaluation of Active Implants in Diabetes Society) and the "Groupe pompe sud-francilien," which he co-founded and brings together a network of diabetologists in the southern Paris region.
A Doctor of Medicine (1990, University of Amiens, France) specializing in endocrine and metabolic disorders since 1992 and a hospital practitioner since 2003, Pauline Schaepelynck-Belicar practices at the Sainte-Marguerite hospital, a part of the Marseille University Hospital in France. A member of the SFD, the EASD study group AIDPIT (Artificial Insulin Delivery, Pancreas and Islet Transplantation) and the ISGIID (International Study Group for Implantable Insulin delivery devices), Pauline Schaepelynck-Belicar is the President of the EVADIAC organization since 2012.
"BIOCORP welcomes the future contribution of these three eminent diabetes specialists who are all actively working with major and internationally recognized scientific societies and are familiar with the main medical and technological — but also industrial — issues surrounding this pathology. Together, they will guide us in developing innovative solutions adapted to the needs of both the medical profession and patients," greeted Jacques Gardette, CEO and founder of BIOCORP.
About BIOCORP
Founded in 2004 in Issoire (near Clermont-Ferrand, France), Biocorp is a French company specializing in the development and manufacturing of medical devices and innovative drug delivery systems. With over twenty years of experience and more than 30 manufactured products, Biocorp is a key player in the industry, providing drug delivery solutions that meet the evolving needs of patients. Today, Biocorp continues to innovate in the area of medical plastics, its core business, and to market traditional devices (alternative to aluminum capsules, syringe and vial administration systems) that have been an important source of recurring income. Its solid expertise and capacity to innovate have allowed the company to develop new internet-connected products, including: the DataPen, a reusable smart injection pen that automatically transmits data to a smartphone app, helping patients manage their treatment; and treatment management add-ons, which adapt to existing delivery devices and are compatible with most injection pens in the market. The company has a team of 35 employees.
For more information, please visit: www.biocorp.fr
Contacts
Biocorp
Eric Dessertenne
Head of Commercial Operations
and Business Development
edessertenne@biocorp.fr
ALIZE RP
Communication agency
Caroline Carmagnol and Valentine Boivin
+33 1 44 54 36 63 / +33 6 83 48 23 27
biocorp@alizerp.com
Help employers find you! Check out all the jobs and post your resume.
Issoire, May 7, 2015 - BIOCORP, a French company specializing in the development and manufacturing of highly innovative medical devices and drug delivery systems, announced today the formation of its Scientific Advisory Board with the appointment of Lutz Heinemann, Ph.D.; Jean-Pierre Riveline, M.D.; and Pauline Schaepelynck-Belicar, M.D.
A Process Engineer (1976, University of Düsseldorf, Germany) and Doctor of Biology (1993, University of Düsseldorf, Germany), Lutz Heinemann began dedicating himself to internal medicine in 1985, when he worked alongside Professor M. Berger at the Clinic for Nutrition and Metabolism, a division of the Centre for Internal Medicine and Neurology at the University of Düsseldorf. In 1999, he founded the Profil Institute for Metabolic Research (Neuss, Germany), a sister institute dedicated to clinical diabetes studies, which, under his leadership, became one of most prominent research centers in the field. Since stepping down as the Head of the institute in 2009, he has maintained some involvement in the center's activities as a scientific advisor. Professor Lutz Heinemann is a member of several scientific societies, including the German Diabetes Association (DDG), European Association for the Study of Diabetes (EASD) and American Diabetes Association (ADA), and he sits on the scientific advisory boards of various pharmaceutical and diagnostic companies. He was a recipient of the "Leadership in Diabetes Technology" award in 2007 and the "Artificial Pancreas Research Award" in 2012 from the Diabetes Technology Society. A coordinator for the European project AP@home from 2010 to 2015, Lutz Heinemann has also served since 2011 as managing editor for the Journal of Diabetes Science and Technology.
A Doctor of Medicine (1998, University of Paris VI, France) and a Doctor of Science (2013, University of Paris VI, France), acting as a lead researcher since 2014, Jean-Pierre Riveline specializes in endocrinology and diabetology at the Cochin and Lariboisière hospitals in Paris, France. His research and teaching focus mainly on the physiological and technological aspects surrounding diabetes. A Member of the EASD and the Société Francophone du Diabète (SFD, French Society of Diabetes), he also serves as general secretary for several nonprofit French organizations dedicated to diabetes, including the French multicenter study group EVADIAC (Evaluation of Active Implants in Diabetes Society) and the "Groupe pompe sud-francilien," which he co-founded and brings together a network of diabetologists in the southern Paris region.
A Doctor of Medicine (1990, University of Amiens, France) specializing in endocrine and metabolic disorders since 1992 and a hospital practitioner since 2003, Pauline Schaepelynck-Belicar practices at the Sainte-Marguerite hospital, a part of the Marseille University Hospital in France. A member of the SFD, the EASD study group AIDPIT (Artificial Insulin Delivery, Pancreas and Islet Transplantation) and the ISGIID (International Study Group for Implantable Insulin delivery devices), Pauline Schaepelynck-Belicar is the President of the EVADIAC organization since 2012.
"BIOCORP welcomes the future contribution of these three eminent diabetes specialists who are all actively working with major and internationally recognized scientific societies and are familiar with the main medical and technological — but also industrial — issues surrounding this pathology. Together, they will guide us in developing innovative solutions adapted to the needs of both the medical profession and patients," greeted Jacques Gardette, CEO and founder of BIOCORP.
About BIOCORP
Founded in 2004 in Issoire (near Clermont-Ferrand, France), Biocorp is a French company specializing in the development and manufacturing of medical devices and innovative drug delivery systems. With over twenty years of experience and more than 30 manufactured products, Biocorp is a key player in the industry, providing drug delivery solutions that meet the evolving needs of patients. Today, Biocorp continues to innovate in the area of medical plastics, its core business, and to market traditional devices (alternative to aluminum capsules, syringe and vial administration systems) that have been an important source of recurring income. Its solid expertise and capacity to innovate have allowed the company to develop new internet-connected products, including: the DataPen, a reusable smart injection pen that automatically transmits data to a smartphone app, helping patients manage their treatment; and treatment management add-ons, which adapt to existing delivery devices and are compatible with most injection pens in the market. The company has a team of 35 employees.
For more information, please visit: www.biocorp.fr
Contacts
Biocorp
Eric Dessertenne
Head of Commercial Operations
and Business Development
edessertenne@biocorp.fr
ALIZE RP
Communication agency
Caroline Carmagnol and Valentine Boivin
+33 1 44 54 36 63 / +33 6 83 48 23 27
biocorp@alizerp.com
Help employers find you! Check out all the jobs and post your resume.